- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 309-323 of
1,014 results
1091 Exhibit: Ansel, Dosage Form Design Biopharmaceutic and Pharmacokinetic C...
Document
IPR2017-01910, No. 1091-91 Exhibit - Ansel, Dosage Form Design Biopharmaceutic and Pharmacokinetic Considerations, Pharmaceutical Dosage Forms and Drug Delivery Systems 101 41 7th...
|
|
Cite Document
1036 Exhibit: Dukes et al, Antiuterotrophic effects of a pure antioestrogen, ICI 182,...
Document
IPR2017-01910, No. 1036-36 Exhibit - Dukes et al, Antiuterotrophic effects of a pure antioestrogen, ICI 182,780 magnetic resonance imaging of the uterus in ovariectomized monkeys, 135 J END...
|
|
Cite Document
2017 Exhibit: Jordan 1995
Document
IPR2017-01910, No. 2017-131 Exhibit - Jordan 1995 (P.T.A.B. Nov. 15, 2017)
|
|
Cite Document
2128 Exhibit: Skougaard 1966
Document
IPR2017-01910, No. 2128-242 Exhibit - Skougaard 1966 (P.T.A.B. Nov. 15, 2017)
|
|
Cite Document
2166 Exhibit: Oleksowicz Mylan Declaration
Document
IPR2017-01910, No. 2166-281 Exhibit - Oleksowicz Mylan Declaration (P.T.A.B. Nov. 15, 2017)
|
|
Cite Document
1081 Exhibit: DrugsFDA Glossary of Terms, US FOOD and DRUG ADMINISTRATIO...
Document
IPR2017-01910, No. 1081-81 Exhibit - DrugsFDA Glossary of Terms, US FOOD and DRUG ADMINISTRATION last updated Feb 2, 2012 (P.T.A.B. Aug. 4, 2017)
|
|
Cite Document
1089 Exhibit: Chwalisz, Modulation of Oestrogenic Effects by Progesterone Antago...
Document
IPR2017-01910, No. 1089-89 Exhibit - Chwalisz, Modulation of Oestrogenic Effects by Progesterone Antagonists in the Rat Uterus, 4 HUMAN REPRODUCTION UPDATE 570 83 1998 (P.T.A.B. A...
|
|
Cite Document
1037 Exhibit: WO 03 006064
Document
IPR2017-01910, No. 1037-37 Exhibit - WO 03 006064 (P.T.A.B. Aug. 4, 2017)
|
|
Cite Document
2098 Exhibit: Aulton Ch 18
Document
IPR2017-01910, No. 2098-212 Exhibit - Aulton Ch 18 (P.T.A.B. Nov. 15, 2017)
|
|
Cite Document
1058 Exhibit: Wakeling, The Future of New Pure Antioestrogens in Clinical Breast C...
Document
IPR2017-01910, No. 1058-58 Exhibit - Wakeling, The Future of New Pure Antioestrogens in Clinical Breast Cancer, 25 BREAST CANCER RESEARCH TREATMENT 1 9 1993 (P.T.A.B. Aug. 4, 20...
|
|
Cite Document
1098 Exhibit: Chien, Solubilization of Steroids by Multiple Co Solvent Systems, 23 C...
Document
IPR2017-01910, No. 1098-98 Exhibit - Chien, Solubilization of Steroids by Multiple Co Solvent Systems, 23 CHEM PHARM BULL 1085 90 1975 (P.T.A.B. Aug. 4, 2017)
|
|
Cite Document
1086 Exhibit: Wilkinson, Tamoxifen Nolvadex Therapy Rationale for Loading Dose F...
Document
IPR2017-01910, No. 1086-86 Exhibit - Wilkinson, Tamoxifen Nolvadex Therapy Rationale for Loading Dose Followed by Maintenance Dose for Patients with Metastatic Breast Cancer, 10 CANCE...
|
|
Cite Document
1053 Exhibit: Nicholson, Pure Antioestrogens in Breast Cancer Experimental and C...
Document
IPR2017-01910, No. 1053-53 Exhibit - Nicholson, Pure Antioestrogens in Breast Cancer Experimental and Clinical Observations, Sex Hormones and Antihormones in Endocrine Dependent Path...
|
|
Cite Document
1012 Exhibit: Declaration of Diane Burgess, PhD and Accompanying Exhibits
Document
IPR2017-01910, No. 1012-12 Exhibit - Declaration of Diane Burgess, PhD and Accompanying Exhibits (P.T.A.B. Aug. 4, 2017)
|
|
Cite Document
1018 Exhibit: DeLuca, Formulation of Small Volume Parenterals, PHARMACEUTIC...
Document
IPR2017-01910, No. 1018-18 Exhibit - DeLuca, Formulation of Small Volume Parenterals, PHARMACEUTICAL DOSAGE FORMS PARENTERAL MEDICATIONS VOLUME 1 Avis ed, 2d ed 1992 (...
|
|
Cite Document
